Rite Aid Corp RAD shares are trading higher Thursday after the company announced better-than-expected financial results and raised full-year revenue guidance above analyst estimates.
Rite Aid reported fiscal first-quarter revenue of $6.01 billion, which beat the estimate of $5.75 billion, according to data from Benzinga Pro. The company reported a quarterly earnings loss of 60 cents per share, which beat the estimate for a loss of 70 cents per share.
Rite Aid raised its full-year fiscal 2023 outlook, citing increased utilization of higher cost drugs at Elixir. The company said it now expects full-year revenue to be between $23.6 billion and $24 billion versus the estimate of $22.91 billion. Rite Aid said it expects a full-year net loss between $246.3 million and $203.3 million.
RAD Price Action: Rite Aid has traded between $20.45 and $4.67 over a 52-week period.
The stock was up 4.32% at $7.01 at time of publication.
Photo: courtesy of Rite Aid.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
